- Summits
- Sponsorship
- Retreats
- Media Opportunities
- News
- About
Healthcare innovation in the United Arab Emirates is no longer developing in isolation. Investors, founders, and policymakers are increasingly moving in step, supported by government initiatives, expanding clinical infrastructure, and a new generation of startups building with global markets in mind. As a result, the region is attracting healthcare investors who are focused on building scalable businesses rather than chasing short-term wins.
From healthtech and AI-driven platforms to wellness and women’s health, investors operating in and from the UAE are playing an active role in shaping how healthcare companies are built, tested, and expanded across MENA and beyond.
Below is a closer look at some of the investment firms and platforms contributing to this momentum, each with a clear thesis, regional commitment, and growing healthcare footprint.
Quadria Capital is one of Asia’s largest healthcare-focused private equity firms, with an active presence in the Middle East and a strong interest in building scalable healthcare platforms across emerging markets. The firm partners with companies across healthcare services, life sciences, medtech, and digital health, supporting them through operational scale-up and regional expansion.
With a long-term view on healthcare delivery and outcomes, Quadria Capital is particularly relevant to founders and growth-stage companies looking to expand across markets with similar demographic and system-level challenges.
Quadria Capital’s approach reflects the increasing role of institutional growth capital in strengthening healthcare infrastructure in and beyond the UAE.
Deerfield Management is a global investment firm dedicated exclusively to healthcare, with investments spanning biopharmaceuticals, medical devices, diagnostics, digital health, and healthcare services. Known for its long-term, research-driven approach, Deerfield partners closely with companies advancing clinically and commercially meaningful solutions.
While global in scope, Deerfield’s engagement with healthcare innovation aligns closely with the UAE’s ambitions to support advanced medical technologies and data-driven healthcare models.
Deerfield Management brings deep sector expertise and patient capital to healthcare companies operating at scale or preparing for their next phase of growth.
Oryx Fund is a MENA-focused investment fund from Hambro Perks, concentrating on early-stage technology companies at late Seed and Series A. With a strong emphasis on backing founders building category-defining businesses, the fund brings global venture experience into the regional ecosystem.
Healthcare and healthtech sit alongside fintech, enterprise tech, logistics tech, and edtech within Oryx’s areas of expertise. Their investment approach reflects the increasing convergence between software, data, and healthcare delivery—particularly relevant in markets where efficiency and access are key challenges.
Oryx Fund’s regional presence and sector depth make it a key participant in early-stage healthcare innovation across the Middle East.
Global Ventures focuses on backing growth-stage, technology-driven founders building globally relevant companies from emerging markets. With healthcare firmly within its investment scope, the firm supports businesses that combine strong fundamentals with cross-border scalability.
Their portfolio reflects an understanding that healthcare solutions developed in markets like the UAE and Egypt can compete internationally, particularly in digital health, health services, and data-driven platforms.
By supporting companies across stages, Global Ventures plays a role in helping healthcare startups move from early validation to sustained growth.
Oraseya Capital is the venture capital arm of the Dubai Integrated Economic Zones Authority, offering founders not only capital but also access to one of the region’s most structured innovation ecosystems.
With a focus on software, fintech, and artificial intelligence, Oraseya Capital is increasingly relevant to healthcare founders building AI-enabled platforms, operational tools, and data solutions that can integrate into regulated environments.
Their positioning at the intersection of policy, infrastructure, and venture capital makes Oraseya Capital a strategic partner for healthcare companies looking to scale responsibly.
DeepMinds operates at the frontier of artificial intelligence and machine learning, with applications spanning social impact, wellness, and veterinary care. While early-stage in its investment approach, the company reflects a broader trend in the UAE: experimentation with AI-driven solutions that address both human and animal health.
Focusing on pre-seed opportunities, DeepMinds supports ideas that explore new models of care, behavioral insight, and intelligent systems capable of learning and adapting over time.
Their work highlights how healthcare investment in the region is expanding beyond traditional clinical settings.
The Case for Her brings a focused lens to women’s health, menstruation, and female sexual health, areas that have historically received limited funding. Through a combination of angel and pre-seed investments, the platform supports founders addressing gaps in wellness, education, and access.
With activity spanning Europe and the Middle East, The Case for Her reflects a growing recognition that women’s health is both an underserved market and a critical component of healthcare systems.
Their presence in the UAE ecosystem signals increasing openness to conversations and investments that address gender-specific health needs.
Together, these investors represent a broader shift underway in the UAE, one where healthcare innovation is supported by capital that understands regulation, regional nuance, and global opportunity.
For founders, this means access to investors who are not only funding companies but actively shaping the conditions needed for healthcare businesses to grow sustainably. For investors, the region continues to offer exposure to talent, unmet clinical needs, and platforms built with international expansion in mind.
These discussions move forward when investors, founders, regulators, and healthcare leaders meet in the same room.
Taking place in Dubai from 11 to 13 February 2026, MedTech World Middle East | Dubai 2026 brings together the people advancing healthcare innovation across the region and beyond, creating space for meaningful conversations, new partnerships, and long-term collaboration.
For investors actively backing medical devices, digital health, and health tech startups, Investor Pass applications are now open. Approved applicants receive an Investor Pass that includes a Platinum-level conference ticket, offering full access to curated networking and closed-door discussions. Applications are reviewed on a rolling basis, and our team may request additional information to ensure alignment. Book your slot before they’re all gone.
